Retina
VIDEO: EYP-1901 shows positive vision, treatment burden outcomes at 1 year
CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Carl D. Regillo, MD, FACS, of Wills Eye Hospital, shares study results from the phase 2 DAVIO 2 trial.
GA and Advances in Imaging and Surgery: State-of-the-Art Management
This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc.; Genentech, a member of the Roche Group.; Neurotech Pharmaceuticals, Inc.; Astellas; EyePoint Pharmaceuticals, Inc.; Opthea Ltd.; Topcon Healthcare, Inc.; Outlook Therapeutics; REGENXBIO Inc.; Ocuphire Pharma; and Carl Zeiss Meditec, Inc.
nAMD, Diabetic Eye Disease, and RVO: State-of-the-Art Management
This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc.; Genentech, a member of the Roche Group.; Neurotech Pharmaceuticals, Inc.; Astellas; EyePoint Pharmaceuticals, Inc.; Opthea Ltd.; Topcon Healthcare, Inc.; Outlook Therapeutics; REGENXBIO Inc.; Ocuphire Pharma; and Carl Zeiss Meditec, Inc.
VIDEO: Ocular Therapeutix shifts to retina-focused treatments
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Peter K. Kaiser, MD, of Ocular Therapeutix, discusses the company’s shift to a retina-focused program.
Optogenetic therapy holds promise for treatment of late-stage geographic atrophy
BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Jordi Monés, MD, PhD, discusses an investigational optogenetic therapy for geographic atrophy.
VIDEO: Specialist offers overview of novel investigational therapies for dry AMD
BARCELONA, Spain – In this Healio Video Perspective at the Euretina congress, Baruch D. Kuppermann, MD, PhD, delivers an overview of new compounds currently under investigation for dry age-related macular degeneration.
VIDEO: Wide-angle visualization, 3D systems useful tools for vitreoretinal surgery
BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Sundaram Natarajan, MD, shares his experience with wide-angle viewing systems.
VIDEO: Verana Health introduces two novel data collection solutions
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Sujay Jadhav, CEO of Verana Health, discusses two of the company’s new data collection modules which launched during the AAO meeting.
FDA grants de novo authorization to photobiomodulation device for dry AMD
The FDA granted de novo marketing authorization Valeda Light Delivery System for the treatment of dry age-related macular degeneration, according to a press release from LumiThera.
Highlights from AAO 2024
In this episode of Meeting Mic, we bring you pearls and perspectives from the American Academy of Ophthalmology 2024 Meeting with a focus on AMD and retina.